Status: Recruiting
Single Session vs Multiple-Session Panretinal Photocoagulation for Treatment of Proliferative Diabetic Retinopathy
Proliferative diabetic retinopathy (PDR) is the leading cause for blindness in working-age adults. The current gold standard treatment for PDR is panretinal photocoagulation (PRP). In current clinical practice, both single-session and multiple-session PRP approaches are widely accepted and utilized. The purpose of this study is to compare the safety and effectiveness of single-session and multiple-session PRP.
Participants needed: 40
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Vastra Gotaland RegionUpdated: Nov 18, 2025Locations: 1
Eligibility criteria
Age > 18 years. [+4]
Intraocular surgery within the last 4 months or planned within the next 3 months... [+5]